Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease. Part I: Pathology,

Insights

Alzheimer's disease (AD) and vascular dementia (VaD) often coexist, challenging their distinct separation. Recognizing this overlap is crucial for accurate diagnosis and understanding of cognitive decline in older adults.

Area of Science:

  • Neurology
  • Geriatrics
  • Neuroscience

Background:

  • Alzheimer's disease (AD) and vascular dementia (VaD) frequently co-occur, suggesting a potential false dichotomy in their classification.
  • Both neurodegenerative and cerebrovascular pathologies exhibit lengthy preclinical phases, often spanning decades.
  • The clinical manifestation of dementia can disproportionately reflect the underlying neuropathology.

Purpose of the Study:

  • To explore the frequent coexistence of Alzheimer's disease and vascular dementia.
  • To discuss the implications of combined pathologies on diagnosis and understanding of cognitive impairment.
  • To evaluate the proposed routine screening for dementia in older adults.

Main Methods:

  • Review of existing literature on the neuropathology and clinical presentation of AD and VaD.
  • Analysis of diagnostic criteria for dementia and mild cognitive impairment.
  • Consideration of proposed government screening initiatives for cognitive decline.

Main Results:

  • The distinction between AD and VaD is often blurred, with mixed pathologies being most common.
  • Clinical symptoms may not directly correlate with the severity of neuropathological changes.
  • The utility and ethical considerations of routine dementia screening in older populations are debated.

Conclusions:

  • The separation of Alzheimer's disease and vascular dementia may be an oversimplification, as mixed pathologies are prevalent.
  • Accurate diagnosis relies on clinical assessment, neuropsychological testing, and specialist evaluation.
  • The implementation of widespread dementia screening requires careful consideration of its value, consent, and counseling protocols.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
21
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
681
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K